Cargando…
From Rheumatoid Factor to Anti-Citrullinated Protein Antibodies and Anti-Carbamylated Protein Antibodies for Diagnosis and Prognosis Prediction in Patients with Rheumatoid Arthritis
Rheumatoid arthritis (RA) is a chronic systemic inflammatory disease mainly involving synovial inflammation and articular bone destruction. RA is a heterogeneous disease with diverse clinical presentations, prognoses and therapeutic responses. Following the first discovery of rheumatoid factors (RFs...
Autores principales: | Wu, Chao-Yi, Yang, Huang-Yu, Luo, Shue-Fen, Lai, Jenn-Haung |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7828258/ https://www.ncbi.nlm.nih.gov/pubmed/33445768 http://dx.doi.org/10.3390/ijms22020686 |
Ejemplares similares
-
Anti-Citrullinated Protein Antibodies in Patients with Rheumatoid Arthritis: Biological Effects and Mechanisms of Immunopathogenesis
por: Wu, Chao-Yi, et al.
Publicado: (2020) -
Role of anti-citrullinated protein antibodies in diagnosis and prognosis of rheumatoid arthritis
por: Puszczewicz, Mariusz, et al.
Publicado: (2011) -
Anti-carbamylated protein antibodies in rheumatoid arthritis patients and their association with rheumatoid factor
por: Othman, Maizatul A., et al.
Publicado: (2017) -
Antibodies to carbamylated α-enolase epitopes in rheumatoid arthritis also bind citrullinated epitopes and are largely indistinct from anti-citrullinated protein antibodies
por: Reed, Evan, et al.
Publicado: (2016) -
Citrullination and Carbamylation in the Pathophysiology of Rheumatoid Arthritis
por: Pruijn, Ger J. M.
Publicado: (2015)